toripalimab,cisplatin,gemcitabine
Shanghai Junshi Bioscience,coherus
['jupiter-02', 'coherus']
#news: thrilled to share, we re presenting final overall survival results of our jupiter-02 study annual meeting, demonstrating statistically significant and clinically meaningful improvement in overall survival for #npc patients. learn more: #asco23 
Leader in developing and commercializing high-quality, high-value biosimilar therapeutics.